Tumor News and Research

RSS

Research demonstrates a double-acting mechanism for fighting triple-negative breast cancer

Zachary Schug, Ph.D., assistant professor in the Molecular and Cellular Oncogenesis Program of the Ellen and Ronald Caplan Cancer Center at The Wistar Institute, has published a new paper in the journal Nature Cancer.

19 Sep 2023

Scientists uncover potential key risk factors for melanomas in children and adolescents

A recent eBioMedicine study found key risk factors associated with the development of melanoma in children and adolescents.

19 Sep 2023

Trajectory of fear of cancer recurrence levels six to 18 months post-breast cancer diagnosis

Researchers examined the predictors of fear of cancer recurrence (FCR) and its trajectory among breast cancer (BC) patients.

19 Sep 2023

New treatment approach effectively treats the most aggressive forms of prostate cancer

Researchers at the University of Chicago Medicine Comprehensive Cancer Center established "proof-of-concept" for a new treatment approach that was able to effectively treat the most aggressive forms of prostate cancer. The treatment showed complete tumor control and long-lasting survival without side effects in a mouse model of advanced prostate cancer.

19 Sep 2023

Adaptive platform trial shows promise for finding new glioblastoma therapies

An innovative phase 2 clinical trial led by Dana-Farber Cancer Institute in collaboration with 10 major brain tumor centers around the country and designed to find new potential treatments for glioblastoma has reported initial results in the Journal of Clinical Oncology. While none of the three therapeutics tested so far improved overall survival of patients, this adaptive platform trial, the first of its kind in neuro-oncology, has the potential to rapidly and efficiently identify therapies that benefit patients.

19 Sep 2023

New CAR T cell therapy approach minimizes severe side effects

In recent years, cancer researchers have hailed the arrival of chimeric antigen receptor T cell (CAR T) therapy, which has delivered promising results, transforming the fight against various forms of cancer. The process involves modifying patients' T-cells to target cancer cells, resulting in remarkable success rates for previously intractable forms of cancer.

19 Sep 2023

Unlocking the secret soldiers: How dendritic cells could revolutionize cancer immunotherapy

A recent review in the journal Immunity delves into the crucial role of dendritic cells (DCs) in shaping T-cell responses in cancer, highlighting their importance in both priming anti-tumor immunity and in ongoing immune interactions within tumors. The findings underscore the potential of DCs as key targets for next-generation cancer immunotherapies.

18 Sep 2023

Wireless molecular-electrical communications for tumor-cell-induced apoptosis

Researchers utilize electricity generated by wireless-induced redox interactions at bio-nanoantennae to cause apoptosis in cancerous cells.

18 Sep 2023

MGI partners with National Cancer Centre Singapore to undergo comprehensive genomic profiling of Asian-Prevalent cancers

MGI Tech Singapore Pte, Ltd. ("MGI"), a company committed to building core tools and technology to lead life science, recently entered a research partnership with National Cancer Centre Singapore ("NCCS") to facilitate comprehensive, multi-dimensional genomic profiling of Asian-prevalent cancers using MGI's core DNBSEQ™ technology.

From MGI 18 Sep 2023

Turning fish waste into cancer fighters: How abalone viscera peptides could be the next big thing in medicine

Researchers explore the potential of bioactive peptides from abalone fish viscera for their antimicrobial and anticancer properties. The study finds promising activity against various bacterial and fungal strains, as well as cytotoxic effects on prostate cancer cells.

17 Sep 2023

Nuvectis launches Phase 1a dose escalation clinical trial of new cancer drug

Clinical trials have begun for a drug candidate for hard-to-treat cancers, discovered at the University of Edinburgh and licensed by US biopharmaceutical company Nuvectis Pharma, Inc.

15 Sep 2023

Is maple syrup the ultimate natural sweetener? Researchers say it's more than just tasty!

Scientists explore the myriad benefits of maple syrup, revealing its nutritional, pharmacological, and sensory advantages over traditional sweeteners. From antioxidant and anti-inflammatory properties to controlling blood sugar and even potential anticancer effects, maple syrup is more than just a tasty topping.

14 Sep 2023

Combination immunotherapy outperforms durvalumab monotherapy in neoadjuvant NSCLC

Combination immunotherapy with the anti-PD-L1 monoclonal antibody durvalumab and other novel agents outperforms durvalumab alone in the neoadjuvant (pre-surgical) setting for early-stage non-small-cell lung cancer (NSCLC), according to researchers at The University of Texas MD Anderson Cancer Center.

14 Sep 2023

MIT study reveals why immunotherapy doesn't work for all cancer patients

This block is broken or missing. You may be missing content or you might need to enable the original module.

14 Sep 2023

Research suggests laminin could play role in slowing progression of breast tumors

Cells are capable of translating mechanical changes into biological responses. This process is known as mechanotransduction and plays a fundamental role in the progression of solid tumors, such as breast cancer.

14 Sep 2023

Harnessing the extraordinary capabilities of bio-nanoantennae to target and kill brain tumors

Researchers have discovered a new way to target and kill cancer cells in hard-to-treat brain tumors using electrically charged molecules to trigger self-destruction, that could be developed into a spray treatment used during surgery.

14 Sep 2023

NIH awards $3.2 million to study how unique DNA circles drive deadly pediatric brain tumors

Lukas Chavez, Ph.D., has received $3.2 million from the National Institutes of Health to study how unique DNA circles found in cancer cells drive deadly pediatric brain tumors.

14 Sep 2023

New trial shows promise of combination neoadjuvant immunotherapy for lung cancer

Patients with stage 1–3 non-small cell lung cancer (NSCLC) given a combination immunotherapy prior to surgery (neoadjuvant) had a better major pathological response (10% or less residual cancer) when the cancer was removed than those who took a single immunotherapy agent alone, according to results of a novel multicenter phase 2 NeoCOAST platform trial that included two investigators from the Johns Hopkins Kimmel Cancer Center and its Bloomberg-Kimmel Institute for Cancer Immunotherapy.

14 Sep 2023

MRI innovation to unveil iron homeostasis in the human brain

Researchers demonstrated a MRI method sensitive to the live brain's iron homeostasis (the r1-r2 extent of relaxation or relaxivity).

14 Sep 2023

AACR Cancer Progress Report provides latest statistics on cancer research and treatment

Today, the American Association for Cancer Research (AACR) released the 13th edition of its annual Cancer Progress Report, which chronicles how basic, translational, and clinical cancer research and cancer-related population sciences - primarily supported by federal investments in the National Institutes of Health (NIH) and the National Cancer Institute (NCI) - remain vitally important to improving health and saving lives.

13 Sep 2023

Tumor News and Research

Research demonstrates a double-acting mechanism for fighting triple-negative breast cancer

Scientists uncover potential key risk factors for melanomas in children and adolescents

Trajectory of fear of cancer recurrence levels six to 18 months post-breast cancer diagnosis

New treatment approach effectively treats the most aggressive forms of prostate cancer

Adaptive platform trial shows promise for finding new glioblastoma therapies

New CAR T cell therapy approach minimizes severe side effects

Unlocking the secret soldiers: How dendritic cells could revolutionize cancer immunotherapy

Wireless molecular-electrical communications for tumor-cell-induced apoptosis

MGI partners with National Cancer Centre Singapore to undergo comprehensive genomic profiling of Asian-Prevalent cancers

Turning fish waste into cancer fighters: How abalone viscera peptides could be the next big thing in medicine

Nuvectis launches Phase 1a dose escalation clinical trial of new cancer drug

Is maple syrup the ultimate natural sweetener? Researchers say it's more than just tasty!

Combination immunotherapy outperforms durvalumab monotherapy in neoadjuvant NSCLC

MIT study reveals why immunotherapy doesn't work for all cancer patients

Research suggests laminin could play role in slowing progression of breast tumors

Harnessing the extraordinary capabilities of bio-nanoantennae to target and kill brain tumors

NIH awards $3.2 million to study how unique DNA circles drive deadly pediatric brain tumors

New trial shows promise of combination neoadjuvant immunotherapy for lung cancer

MRI innovation to unveil iron homeostasis in the human brain

AACR Cancer Progress Report provides latest statistics on cancer research and treatment

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News